No quarterly revenue total was found in COMPASS Pathways plc's SEC filings.
COMPASS Pathways plc (CMPS) files with the SEC under industry code 2834, Pharmaceutical Preparations. As of Sep 30, 2026 it held $444.0 million in cash and investments and $54.4 million in total debt.
Revenue
—
Net income
$-9.83M
+92.9% vs year-ago quarter
Operating cash flow
$-50.77M
-44.6% vs year-ago quarter
Free cash flow
$-41.76M
EPS
$-0.31
+78.5% vs year-ago quarter
Dividend per share
None
Shares outstanding
141.71M
+47.6% vs year-ago quarter
Net cash
$389.58M
Q3 FY2026
Operating margin
—
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CMPS (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- United Kingdom
- Headquarters
- Chesire, United Kingdom
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1816590
- Former names
- Compass Rx Ltd. (until Aug 10, 2020)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Operating income | -$56.4M | -$52.4M | -$42.9M | -$46.0M | -$40.5M |
| Net income | -$9.8M | -$253.8M | $91.2M | -$93.9M | -$137.7M |
| Diluted EPS | -$0.31 | -$1.88 | -$0.30 | -$0.98 | -$1.44 |
| Operating cash flow | -$50.8M | -$40.3M | -$47.9M | -$37.8M | -$35.1M |
| Total assets | $519.1M | $504.6M | $531.7M | $210.3M | $255.6M |
| Total liabilities | $377.0M | $420.0M | $205.1M | $263.2M | $218.0M |
| Stockholders' equity | $142.1M | $84.5M | $326.7M | -$52.8M | $37.6M |
| Cash and investments | $444.0M | $433.3M | $466.0M | $149.6M | $185.9M |
| Total debt | $54.4M | $54.6M | $53.3M | $35.0M | $35.2M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Nov 3, 2026 | Nov 3, 2026 |
| 10-Q | Quarterly report | Nov 3, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2026 | Aug 5, 2026 |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 7, 2026 | Jul 7, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 28, 2026 | May 27, 2026 |
All 344 COMPASS Pathways plc SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.